The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCOLADE INC | COM | 00437E102 | 380 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 165 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 778 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 868 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| GRITSTONE BIO INC | COM | 39868T105 | 320 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 468 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 355 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
| TCR2 THERAPEUTICS INC | COM | 87808K106 | 492 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| THE BEAUTY HEALTH COMPANY | COM CL A | 88331L108 | 168 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,815 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 532 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||